Leah Zajdlewicz1, Melissa K Hyde, Stephen J Lepore, Robert A Gardiner, Suzanne K Chambers. 1. Author Affiliations: Cancer Council Queensland, Brisbane, and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia (Ms Zajdlewicz and Dr Hyde and Prof Chambers); Department of Social and Behavioral Sciences, Temple University, Philadelphia, Pennsylvania (Prof Lepore); University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane (Prof Gardiner); and Prostate Cancer Foundation of Australia, Sydney, and Exercise Medicine Research Institute, Edith Cowan University, Perth (Prof Chambers), Australia.
Abstract
BACKGROUND: Approximately 20% of men with a diagnosis of prostate cancer present with locally advanced or advanced disease. Few studies consider longer-term impact of disease progression and treatment adverse effects on health-related quality of life (QoL) of these men. OBJECTIVE: Describe changes in health-related QoL over 5 years for men with newly diagnosed locally advanced or advanced prostate cancer. INTERVENTIONS/ METHODS: Eighty-one men with locally advanced or advanced prostate cancer referred to the study by their treating urologist completed a self-administered questionnaire assessing distress, cancer-specific distress, decision regret, satisfaction with life, and global and disease-specific health-related QoL. Questionnaires were administered close to diagnosis (baseline), 2, 6, 12, 24, 36, 48, and 60 months' follow-up. RESULTS: Men were of mean age 68.3 (SD, 7.9) years and at mean of 31.9 (SD, 50.5) days postdiagnosis. The most common treatment received was androgen deprivation therapy (95.1%) or radiation therapy (79%). The proportion of men classified as distressed (Distress Thermometer) ranged from 46.3% (baseline) to 32.6% (60 months). Decrements in physical QoL were found at 2, 6, 12, 24, 36, and 48 months compared with baseline. Life satisfaction ratings were lower at 6 months compared with baseline. Sexual concerns were consistently high across the 5 years (Expanded Prostate Cancer Index Composite <30). CONCLUSIONS: In the context of advanced disease, results indicate that health-related QoL fluctuates from diagnosis to 5 years later. A substantial proportion remained distressed at 5-year follow-up. IMPLICATIONS FOR PRACTICE: Care frameworks supporting ongoing assessment of health-related QoL concerns of men with advanced prostate cancer are needed with a particular focus on sexual adjustment.
BACKGROUND: Approximately 20% of men with a diagnosis of prostate cancer present with locally advanced or advanced disease. Few studies consider longer-term impact of disease progression and treatment adverse effects on health-related quality of life (QoL) of these men. OBJECTIVE: Describe changes in health-related QoL over 5 years for men with newly diagnosed locally advanced or advanced prostate cancer. INTERVENTIONS/ METHODS: Eighty-one men with locally advanced or advanced prostate cancer referred to the study by their treating urologist completed a self-administered questionnaire assessing distress, cancer-specific distress, decision regret, satisfaction with life, and global and disease-specific health-related QoL. Questionnaires were administered close to diagnosis (baseline), 2, 6, 12, 24, 36, 48, and 60 months' follow-up. RESULTS:Men were of mean age 68.3 (SD, 7.9) years and at mean of 31.9 (SD, 50.5) days postdiagnosis. The most common treatment received was androgen deprivation therapy (95.1%) or radiation therapy (79%). The proportion of men classified as distressed (Distress Thermometer) ranged from 46.3% (baseline) to 32.6% (60 months). Decrements in physical QoL were found at 2, 6, 12, 24, 36, and 48 months compared with baseline. Life satisfaction ratings were lower at 6 months compared with baseline. Sexual concerns were consistently high across the 5 years (Expanded Prostate Cancer Index Composite <30). CONCLUSIONS: In the context of advanced disease, results indicate that health-related QoL fluctuates from diagnosis to 5 years later. A substantial proportion remained distressed at 5-year follow-up. IMPLICATIONS FOR PRACTICE: Care frameworks supporting ongoing assessment of health-related QoL concerns of men with advanced prostate cancer are needed with a particular focus on sexual adjustment.
Authors: Jiayi Du; Ling Fu; Jiaxin Cui; Zifen An; Pei Fang; Lanhui Tan; Xianmei Meng; Liping Yu Journal: Int J Environ Res Public Health Date: 2022-05-17 Impact factor: 4.614
Authors: Frank J Penedo; Rina S Fox; Laura B Oswald; Patricia I Moreno; Cody L Boland; Ryne Estabrook; Heather L McGinty; David C Mohr; Mark J Begale; Jason R Dahn; Sarah C Flury; Kent T Perry; Shilajit D Kundu; Betina Yanez Journal: Int J Behav Med Date: 2020-10
Authors: Blanca Noriega Esquives; Tae K Lee; Patricia I Moreno; Rina S Fox; Betina Yanez; Gregory E Miller; Ryne Estabrook; Mark J Begale; Sarah C Flury; Kent Perry; Shilajit D Kundu; Frank J Penedo Journal: J Behav Med Date: 2022-02-02
Authors: Agnieszka Lemanska; Karen Poole; Bruce A Griffin; Ralph Manders; John M Saxton; Lauren Turner; Joe Wainwright; Sara Faithfull Journal: BMJ Open Date: 2019-06-11 Impact factor: 2.692
Authors: Jeff Dunn; Anna Green; Nicholas Ralph; Robert U Newton; Andrew Kneebone; Mark Frydenberg; Suzanne K Chambers Journal: BJU Int Date: 2020-08-18 Impact factor: 5.969